Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5845641 | Pulmonary Pharmacology & Therapeutics | 2015 | 10 Pages |
Abstract
The segmental LPS challenge model was safe. Future study designs have to balance between burden to the study subjects (4 versus 2 bronchoscopies), variability (within-versus between-subject), and the desired outcome variable (cells versus chemo/cytokine).
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
O. Holz, L. Tan, F. Schaumann, M. Müller, D. Scholl, R. Hidi, A. McLeod, N. Krug, J.M. Hohlfeld,